These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15200344)

  • 1. Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.
    Cowley BD
    Drugs; 2004; 64(12):1285-94. PubMed ID: 15200344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine models of polycystic kidney disease: molecular and therapeutic insights.
    Guay-Woodford LM
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic kidney disease and therapeutic approaches.
    Park EY; Woo YM; Park JH
    BMB Rep; 2011 Jun; 44(6):359-68. PubMed ID: 21699747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
    Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
    Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic kidney disease--a truly pediatric problem.
    Ogborn MR
    Pediatr Nephrol; 1994 Dec; 8(6):762-7. PubMed ID: 7696122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
    Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hereditary model of slowly progressive polycystic kidney disease in the mouse.
    Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH
    J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of proteins, lipids, and phytochemicals in the prevention of polycystic kidney disease progression and severity.
    Maditz KH; Gigliotti JC; Tou JC
    Nutr Rev; 2013 Dec; 71(12):802-14. PubMed ID: 24246056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic advances in the treatment of polycystic kidney disease.
    Riella C; Czarnecki PG; Steinman TI
    Nephron Clin Pract; 2014; 128(3-4):297-302. PubMed ID: 25573484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Fibrosis in Polycystic Kidney Disease.
    Song CJ; Zimmerman KA; Henke SJ; Yoder BK
    Results Probl Cell Differ; 2017; 60():323-344. PubMed ID: 28409351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary n-3 polyunsaturated fatty acids or soy protein isolate did not attenuate disease progression in a female rat model of autosomal recessive polycystic kidney disease.
    Maditz KH; Oldaker C; Nanda N; Benedito V; Livengood R; Tou JC
    Nutr Res; 2014 Jun; 34(6):526-34. PubMed ID: 25026920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising the management of polycystic kidney disease.
    Keenan D; Maxwell AP
    Practitioner; 2016 Feb; 260(1790):13-6, 2. PubMed ID: 27032221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease.
    Sagar PS; Zhang J; Luciuk M; Mannix C; Wong ATY; Rangan GK
    PLoS One; 2019; 14(1):e0209186. PubMed ID: 30601830
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.